Tenascin-C inhibitors belong to a distinctive chemical class characterized by their capability to modulate the activity of Tenascin-C, an extracellular matrix protein that plays a vital role in tissue development, wound healing, and various cellular processes. These inhibitors function by interfering with the interactions involving Tenascin-C, which is prominently expressed during tissue remodeling and repair. Tenascin-C contributes to cell adhesion, migration, and signaling, facilitating dynamic cellular responses. Tenascin-C inhibitors are thoughtfully designed to target specific binding sites or molecular pathways associated with Tenascin-C, thus influencing its cellular functions and downstream effects.
The development of Tenascin-C inhibitors necessitates a profound understanding of the structural characteristics of Tenascin-C and its interactions with cells and other extracellular components. Researchers in this field work to engineer molecules with high selectivity and affinity for Tenascin-C, allowing for precise modulation of its activities. These inhibitors often utilize innovative design strategies that disrupt pivotal molecular interactions essential for Tenascin-C's functional roles. By gaining insights into the intricate mechanisms through which Tenascin-C participates in tissue dynamics and cellular responses, researchers aim to uncover its significance in fundamental biological phenomena. The ongoing advancements in applications across diverse scientific domains where manipulation of Tenascin-C-mediated processes is of interest.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
4-Methylumbelliferone | 90-33-5 | sc-206910 sc-206910A sc-206910B sc-206910C sc-206910D | 25 g 100 g 250 g 1 kg 2.5 kg | $35.00 $56.00 $141.00 $431.00 $973.00 | 2 | |
4-Methylumbelliferone (4-MU) has been studied for its potential to inhibit tenascin-C production and mitigate fibrosis | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Originally developed as an integrin inhibitor for cancer, this compound has also shown inhibitory effects on tenascin-C interactions | ||||||